These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24953400)

  • 1. Combination of statin plus renin angiotensin system inhibition for the prevention or the treatment of atherosclerotic cardiovascular disease.
    Athyros VG; Katsiki N; Karagiannis A; Mikhailidis DP
    Curr Pharm Des; 2014; 20(40):6299-305. PubMed ID: 24953400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin-angiotensin system inhibitor and statins combination therapeutics - what have we learnt?
    Koh KK; Sakuma I; Hayashi T; Kim SH; Chung WJ
    Expert Opin Pharmacother; 2015 May; 16(7):949-53. PubMed ID: 25747324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of miR-146a/b is associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin-angiotensin system blockade and statins on miRNA-146a/b and Toll-like receptor 4 levels.
    Takahashi Y; Satoh M; Minami Y; Tabuchi T; Itoh T; Nakamura M
    Clin Sci (Lond); 2010 Jul; 119(9):395-405. PubMed ID: 20524934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins and renin-angiotensin system inhibitor combination treatment to prevent cardiovascular disease.
    Lee HY; Sakuma I; Ihm SH; Goh CW; Koh KK
    Circ J; 2014; 78(2):281-7. PubMed ID: 24401609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cardiovascular events in patients with angiographically documented coronary narrowing with combined renin-angiotensin system inhibitor plus statin versus renin-angiotensin system inhibitor alone versus statin alone (from the Japanese Coronary Artery Disease Study).
    Fujita M; Yamazaki T; Hayashi D; Kohro T; Okada Y; Nagai R;
    Am J Cardiol; 2007 Dec; 100(12):1750-3. PubMed ID: 18082520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined effects of HMG-CoA-reductase inhibition and renin-angiotensin system blockade on experimental atherosclerosis.
    Grothusen C; Bley S; Selle T; Luchtefeld M; Grote K; Tietge UJ; Drexler H; Schieffer B
    Atherosclerosis; 2005 Sep; 182(1):57-69. PubMed ID: 16115475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial Protection, AT1 blockade and Cholesterol-Dependent Oxidative Stress: the EPAS trial.
    Morawietz H; Erbs S; Holtz J; Schubert A; Krekler M; Goettsch W; Kuss O; Adams V; Lenk K; Mohr FW; Schuler G; Hambrecht R
    Circulation; 2006 Jul; 114(1 Suppl):I296-301. PubMed ID: 16820589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive statin therapy for Indians: Part-I. Benefits.
    Enas EA; Pazhoor HC; Kuruvila A; Vijayaraghavan K
    Indian Heart J; 2011; 63(3):211-27. PubMed ID: 22734339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin therapy for vascular failure.
    Inoue T; Node K
    Cardiovasc Drugs Ther; 2007 Aug; 21(4):281-95. PubMed ID: 17682928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin-angiotensin system antagonism and lipid-lowering therapy in cardiovascular risk management.
    Chiong JR; Miller AB
    J Renin Angiotensin Aldosterone Syst; 2002 Jun; 3(2):96-102. PubMed ID: 12228849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy of candesartan with statin inhibits progression of atherosclerosis more than statin alone in patients with coronary artery disease.
    Suzuki T; Nozawa T; Fujii N; Sobajima M; Ohori T; Shida T; Matsuki A; Kameyama T; Inoue H
    Coron Artery Dis; 2011 Aug; 22(5):352-8. PubMed ID: 21494127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
    Koenig W
    Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins, the renin-angiotensin-aldosterone system and hypertension - a tale of another beneficial effect of statins.
    Drapala A; Sikora M; Ufnal M
    J Renin Angiotensin Aldosterone Syst; 2014 Sep; 15(3):250-8. PubMed ID: 25037529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleiotropic effects of statins--clinical evidence.
    Athyros VG; Kakafika AI; Tziomalos K; Karagiannis A; Mikhailidis DP
    Curr Pharm Des; 2009; 15(5):479-89. PubMed ID: 19199976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial.
    Mora S; Caulfield MP; Wohlgemuth J; Chen Z; Superko HR; Rowland CM; Glynn RJ; Ridker PM; Krauss RM
    Circulation; 2015 Dec; 132(23):2220-9. PubMed ID: 26408274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological basis of different targets for the treatment of atherosclerosis.
    Saini HK; Xu YJ; Arneja AS; Tappia PS; Dhalla NS
    J Cell Mol Med; 2005; 9(4):818-39. PubMed ID: 16364193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.
    Reiner Z
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):799-807. PubMed ID: 23932901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. To RAS or not to RAS? The evidence for and cautions with renin-angiotensin system inhibition in patients with diabetic kidney disease.
    St Peter WL; Odum LE; Whaley-Connell AT
    Pharmacotherapy; 2013 May; 33(5):496-514. PubMed ID: 23576066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of atherosclerosis, blood pressure and arterial elasticity by statins.
    Sinha AK; Mehta JL
    Adv Cardiol; 2007; 44():315-330. PubMed ID: 17075218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.